STOKELY DAN 4
4 · Ampio Pharmaceuticals, Inc. · Filed May 19, 2021
Insider Transaction Report
Form 4
STOKELY DAN
CFO
Transactions
- Sale
Common Stock
2021-05-18$1.83/sh−35,000$63,980→ 28,315 total - Exercise/Conversion
Common Stock
2021-05-17$0.43/sh+35,000$15,050→ 63,315 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-17−35,000→ 283,000 totalExercise: $0.43Exp: 2029-08-20→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.